Core Insights - The company, MicroPort Scientific Corporation, reported that its cumulative order volume for core products in the fields of endoscopy, orthopedics, and vascular intervention has exceeded 230 units [1] - The Tumi endoscopic surgical robot has achieved over 160 commercial orders globally, with nearly 120 new orders acquired this year, positioning it among the top two in global order volume for 2025 [1] - The company has completed over 150 commercial installations of its products, with Tumi surpassing 100 installations, all of which have received signed acceptance reports from users [1] Product Performance - Tumi is the first domestically produced endoscopic surgical robot to achieve over 100 commercial installations, demonstrating its reliability and clinical stability at an industry infrastructure level [1] - The advancements in Tumi's quality compliance, production processes, engineering validation, system delivery, clinical adaptation, and overall process assurance capabilities signify a comprehensive leap in its operational standards [1]